-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Outperform on Cardinal Health, Raises Price Target to $170

Benzinga·05/02/2025 12:28:00
Listen to the news
Baird analyst Eric Coldwell maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $156 to $170.